Association between early-onset Parkinson's disease and mutations in the parkin gene - PubMed (original) (raw)
. 2000 May 25;342(21):1560-7.
doi: 10.1056/NEJM200005253422103.
A Dürr, V Bonifati, J Vaughan, G De Michele, T Gasser, B S Harhangi, G Meco, P Denèfle, N W Wood, Y Agid, A Brice; French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease
Affiliations
- PMID: 10824074
- DOI: 10.1056/NEJM200005253422103
Free article
Association between early-onset Parkinson's disease and mutations in the parkin gene
C B Lücking et al. N Engl J Med. 2000.
Free article
Abstract
Background: Mutations in the parkin gene have recently been identified in patients with early-onset Parkinson's disease, but the frequency of the mutations and the associated phenotype have not been assessed in a large series of patients.
Methods: We studied 73 families in which at least one of the affected family members was affected at or before the age of 45 years and had parents who were not affected, as well as 100 patients with isolated Parkinson's disease that began at or before the age of 45 years. All subjects were screened for mutations in the parkin gene with use of a semiquantitative polymerase-chain-reaction assay that simultaneously amplified several exons. We sequenced the coding exons in a subgroup of patients. We also compared the clinical features of patients with parkin mutations and those without mutations.
Results: Among the families with early-onset Parkinson's disease, 36 (49 percent) had parkin mutations. The age at onset ranged from 7 to 58 years. Among the patients with isolated Parkinson's disease, mutations were detected in 10 of 13 patients (77 percent) with an age at onset of 20 years or younger, but in only 2 of 64 patients (3 percent) with an age at onset of more than 30 years. The mean (+/-SD) age at onset in the patients with parkin mutations was younger than that in those without mutations (32+/-11 vs. 42+/-11 years, P<0.001), and they were more likely to have symmetric involvement and dystonia at onset, to have hyperreflexia at onset or later, to have a good response to levodopa therapy, and to have levodopa-induced dyskinesias during treatment. Nineteen different rearrangements of exons (deletions and multiplications) and 16 different point mutations were detected.
Conclusions: Mutations in the parkin gene are a major cause of early-onset autosomal recessive familial Parkinson's disease and isolated juvenile-onset Parkinson's disease (at or before the age of 20 years). Accurate diagnosis of these cases cannot be based only on the clinical manifestations of the disease.
Similar articles
- A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.
Abbas N, Lücking CB, Ricard S, Dürr A, Bonifati V, De Michele G, Bouley S, Vaughan JR, Gasser T, Marconi R, Broussolle E, Brefel-Courbon C, Harhangi BS, Oostra BA, Fabrizio E, Böhme GA, Pradier L, Wood NW, Filla A, Meco G, Denefle P, Agid Y, Brice A. Abbas N, et al. Hum Mol Genet. 1999 Apr;8(4):567-74. doi: 10.1093/hmg/8.4.567. Hum Mol Genet. 1999. PMID: 10072423 - Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype.
Klein C, Pramstaller PP, Kis B, Page CC, Kann M, Leung J, Woodward H, Castellan CC, Scherer M, Vieregge P, Breakefield XO, Kramer PL, Ozelius LJ. Klein C, et al. Ann Neurol. 2000 Jul;48(1):65-71. Ann Neurol. 2000. PMID: 10894217 - Parkin mutations are frequent in patients with isolated early-onset parkinsonism.
Periquet M, Latouche M, Lohmann E, Rawal N, De Michele G, Ricard S, Teive H, Fraix V, Vidailhet M, Nicholl D, Barone P, Wood NW, Raskin S, Deleuze JF, Agid Y, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group; European Consortium on Genetic Susceptibility in Parkinson's Disease. Periquet M, et al. Brain. 2003 Jun;126(Pt 6):1271-8. doi: 10.1093/brain/awg136. Brain. 2003. PMID: 12764050 - [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N. Hattori N. Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Rinsho Shinkeigaku. 2004. PMID: 15287506 Review. Japanese. - Significance of the parkin gene and protein in understanding Parkinson's disease.
Fishman PS, Oyler GA. Fishman PS, et al. Curr Neurol Neurosci Rep. 2002 Jul;2(4):296-302. doi: 10.1007/s11910-002-0004-7. Curr Neurol Neurosci Rep. 2002. PMID: 12044248 Review.
Cited by
- Association between osteoarthritis with Parkinson's disease in the US (NHANES 2011-2020).
Liu Y, Zhou X, Chen C, Li X, Pan T, Liu Z, Wu D, Chen X. Liu Y, et al. Front Neurosci. 2024 Aug 21;18:1393740. doi: 10.3389/fnins.2024.1393740. eCollection 2024. Front Neurosci. 2024. PMID: 39234184 Free PMC article. - The Utility of Long-Read Sequencing in Diagnosing Genetic Autosomal Recessive Parkinson's Disease: a genetic screening study.
Daida K, Yoshino H, Malik L, Baker B, Ishiguro M, Genner R, Paquette K, Li Y, Nishioka K, Masuzugawa S, Hirano M, Takahashi K, Kolmogolv M, Billingsley KJ, Funayama M, Blauwendraat C, Hattori N. Daida K, et al. medRxiv [Preprint]. 2024 Jun 15:2024.06.14.24308784. doi: 10.1101/2024.06.14.24308784. medRxiv. 2024. PMID: 39108517 Free PMC article. Preprint. - Oxidative Stress and Neurodegeneration: Insights and Therapeutic Strategies for Parkinson's Disease.
Bej E, Cesare P, Volpe AR, d'Angelo M, Castelli V. Bej E, et al. Neurol Int. 2024 Apr 29;16(3):502-517. doi: 10.3390/neurolint16030037. Neurol Int. 2024. PMID: 38804477 Free PMC article. Review. - PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants.
Clausen L, Okarmus J, Voutsinos V, Meyer M, Lindorff-Larsen K, Hartmann-Petersen R. Clausen L, et al. Cell Mol Life Sci. 2024 May 20;81(1):223. doi: 10.1007/s00018-024-05262-8. Cell Mol Life Sci. 2024. PMID: 38767677 Free PMC article. Review. - PARKIN is not required to sustain OXPHOS function in adult mammalian tissues.
Filograna R, Gerlach J, Choi HN, Rigoni G, Barbaro M, Oscarson M, Lee S, Tiklova K, Ringnér M, Koolmeister C, Wibom R, Riggare S, Nennesmo I, Perlmann T, Wredenberg A, Wedell A, Motori E, Svenningsson P, Larsson NG. Filograna R, et al. NPJ Parkinsons Dis. 2024 Apr 29;10(1):93. doi: 10.1038/s41531-024-00707-0. NPJ Parkinsons Dis. 2024. PMID: 38684669 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases